Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
April 1, 1992
Renal cell carcinoma treated with continuous-infusion interleukin-2 with ex vivo-activated killer cells
K A Foon, P J Walther, Z P Bernstein, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
April 1, 1991
Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease
Z P Bernstein, L Vaickus, N Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen
K A Foon, A R Oseroff, L Vaickus, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
October 1, 1991
Interleukin-2 with ex vivo activated killer cells: therapy of advanced non-small-cell lung cancer
Z P Bernstein, M H Goldrosen, L Vaickus, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy
P S Ritch, C Keever, J Schiller, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 1, 1996
Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer
R W Byhardt, L Vaickus, P L Witt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1996
Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity
N J Meropol, M Porter, L E Blumenson, et al.
American Journal of Surgery
|
September 1, 1996
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery
N J Meropol, N J Petrelli, B J Lipman, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
April 1, 1992
Renal cell carcinoma treated with continuous-infusion interleukin-2 with ex vivo-activated killer cells
K A Foon, P J Walther, Z P Bernstein, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
April 1, 1991
Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease
Z P Bernstein, L Vaickus, N Friedman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen
K A Foon, A R Oseroff, L Vaickus, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
October 1, 1991
Interleukin-2 with ex vivo activated killer cells: therapy of advanced non-small-cell lung cancer
Z P Bernstein, M H Goldrosen, L Vaickus, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy
P S Ritch, C Keever, J Schiller, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
November 1, 1996
Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer
R W Byhardt, L Vaickus, P L Witt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1996
Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity
N J Meropol, M Porter, L E Blumenson, et al.
American Journal of Surgery
|
September 1, 1996
Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery
N J Meropol, N J Petrelli, B J Lipman, et al.
Page
of 3